Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

656
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
656
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

724
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
724
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.1K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

301
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
301
Causality in Epidemiology01:21

Causality in Epidemiology

1.8K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.8K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

56
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
56

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Knowledge-Augmented Large Language Model for Multimodal Electronic Health Record-Based Risk Prediction: Development and Validation Study.

JMIR AI·2026
Same author

The seventh kidney cancer research summit: progress in accelerating cures.

The oncologist·2026
Same author

Assessing the Impact of Timing and Coverage of United States COVID-19 Vaccination Campaigns: A Multi-Model Approach.

medRxiv : the preprint server for health sciences·2026
Same author

Integrated framework to study genomic surveillance of selective sweeps in multivariants dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Scenario-aware control of multipathway spread processes: Application to biological invasions.

PNAS nexus·2026
Same author

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

CA: a cancer journal for clinicians·2025
Same journal

Spatio-temporal modeling of zoonotic cutaneous leishmaniasis (ZCL) in the Algerian steppe: Epidemiological insights and climatic associations.

Epidemics·2026
Same journal

Measuring the growth of infectious disease modelling publications and their impact on policymaking: A large language model-assisted bibliometric review.

Epidemics·2026
Same journal

Identifying memory mechanisms in Bayesian models of behavioural change during epidemics.

Epidemics·2026
Same journal

Mapping the landscape of individual-based models for respiratory pathogen transmission in the pandemic and post-pandemic era (2020-2024): A systematic review.

Epidemics·2026
Same journal

A stochastic meta-population model of Ebola virus disease transmission for informing public health decisions.

Epidemics·2026
Same journal

Modelling serological cross-reactivity to disentangle the dynamics of West Nile and Usutu viruses in an emerging area.

Epidemics·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K

Using data-driven agent-based models for forecasting emerging infectious diseases.

Srinivasan Venkatramanan1, Bryan Lewis1, Jiangzhuo Chen1

  • 1Network Dynamics and Simulation Science Laboratory, Biocomplexity Institute of Virginia Tech, United States.

Epidemics
|March 4, 2017
PubMed
Summary
This summary is machine-generated.

Developing accurate infectious disease forecasts is difficult due to data limitations and changing dynamics. This study presents an agent-based model framework for predicting the 2014-2015 Ebola epidemic in Liberia, offering insights for future epidemic preparedness.

Keywords:
Agent-based modelsBayesian calibrationEbolaEmerging infectious diseasesSimulation optimization

More Related Videos

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research
08:48

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research

Published on: May 24, 2024

2.7K

Related Experiment Videos

Last Updated: Mar 6, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K
Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research
08:48

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research

Published on: May 24, 2024

2.7K

Area of Science:

  • Epidemiology
  • Computational modeling
  • Infectious disease dynamics

Background:

  • Forecasting emerging infectious diseases presents significant challenges, including poor data quality and limited understanding of disease transmission.
  • Policy decisions during epidemics require timely and reliable predictions, which are often hindered by complex, dynamic factors.

Purpose of the Study:

  • To describe an agent-based model (ABM) framework developed for forecasting the 2014-2015 Ebola epidemic in Liberia.
  • To evaluate the model's performance and utility in a real-world epidemic scenario and forecasting challenge.

Main Methods:

  • Development of a detailed agent-based model integrating disease dynamics and social behavior.
  • Calibration of the model using available data from the Ebola epidemic in Liberia.
  • Summarization and analysis of forecast performance across various scenarios during the Ebola forecasting challenge.

Main Results:

  • The agent-based model provided a framework for integrating diverse data sources to model epidemic spread.
  • The model's performance was assessed against actual epidemic trajectories during the forecasting challenge.
  • Key components and calibration strategies for the model were detailed.

Conclusions:

  • Data-driven computational models, such as the described ABM, offer a valuable approach for understanding and forecasting epidemic dynamics.
  • The framework can be refined and adapted for preparedness and response to future infectious disease outbreaks.
  • Lessons learned from the Ebola epidemic forecasting challenge provide insights for improving epidemic modeling and response strategies.